Aarti Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NIACIN, with a corresponding US DMF Number 20051.
Remarkably, this DMF maintains an Active status since its submission on December 14, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 10, 2013, and payment made on April 03, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II